- Restoration of lymphokine-activated killer cell response with indomethacin in tumor bearing mice
-
Yun YS, Jung IS, Yun JS
- KMID: 2082992
- Korean J Immunol.
- 1993 Nov;15(2):255-261.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of interferon-alpha and -gamma on lymphokine-activated killer cell activity induced by interleukin-2
-
Choi Y, Choi YK, Kim JM, Chung YH, Kim KH, Han WS
- KMID: 1687990
- J Korean Soc Microbiol.
- 1992 Aug;27(4):371-380.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Change of NK Cell and LAK Cell Activity of Cancer Patients in Postchemotherapy Period
-
Chung CS, Choeh K, Choi YM
- KMID: 1682857
- J Korean Pediatr Soc.
- 1989 Jul;32(7):933-942.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Lymphokine-activated killer(LAK) Cell Activity and Phenotypic Characterization in Peripheral Lymphocytes of Patients with Cervical Cancer
-
Kim SR, Kim KT, Cho SH, Hwang YY, Lee JA, Moon H, Kim JM, Cho YJ
- KMID: 2083705
- Korean J Gynecol Oncol Colposc.
- 1992 Mar;3(1):10-23.
In adoptive immunotherapy of cancer using lymphokine-activated killer(LAK) cells indueed from patients own peripheral blood, the efficient cytotoxicity of LAK cells is a principal requirement. Peripheral blood lyrnphocytes were obtained... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of hepatoma with hepatic artery infusion of LAK cell and intravenous interleukin-2
-
Lee KS, Kim BR, Choi SH
- KMID: 1685441
- Korean J Gastroenterol.
- 1992 Aug;24(4):798-808.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of target cell nitric oxide synthesis on the sensitivity to lymphokine-activated killer cell cytotoxicity
-
Park SI, Park JH, Lee CK, Kim SC, Choi BG, Kwak JY, Yim CY
- KMID: 2054227
- Immune Netw.
- 2001 Aug;1(2):162-169.
- doi: 10.4110/in.2001.1.2.162
BACKGROUND: Nitric oxide (NO), a cytotoxic molecule is produced in various tissues including tumor cells during interleukin-2 (IL-2) therapy . Lymphokine-activated killer (LAK) cells are induced during IL-2 therapy, and... -
- CITED
-
- Close
- SHARE
-
- Close
- The effect of interleukin 2 on the induction Of Nk 1.1 expression in CD8+ and CD4-CD8-T Cell
-
Cho YJ, Chang YH
- KMID: 2286159
- J Asthma Allergy Clin Immunol.
- 1998 Jun;18(2):290-298.
BACKGROUND: Murine IL-2-induced lymphokine-activated killers can be divided into two mutually exclusive subset:NK1.1'CD8 and NK1.1 CD8+. However, there is a strong evidence that NK cell may belong to T cell lineage. Recently... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of nitric oxide (NO) synthesis inhibition on antitumor responses during interleukin-2 (IL-2) treatment of mice
-
Yim CY, Lee CW, Choi SM, Park SS, Lee SJ, Kim JH, Song JS, Yoo WH, Kwak JY, Sohn MH
- KMID: 1051549
- Korean J Intern Med.
- 1996 Jun;11(2):93-100.
OBJECTIVES: To evaluate if L-arginine: NO pathway is activated in tumor tissues during IL-2 therapy and to evaluate whether IL-2 induced NO synthesis represents an antitumor effector mechanism or an... -
- CITED
-
- Close
- SHARE
-
- Close
